Radiohybrid prostate-specific membrane antigen ligand: new frontier in prostate cancer imaging and therapy

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)893-896
Number of pages4
JournalTranslational Andrology and Urology
Volume13
Issue number5
DOIs
StatePublished - May 31 2024

Keywords

  • LIGHTHOUSE trial
  • Radiohybrid prostate-specific membrane antigen ligands (rh PSMA ligands)
  • prostate carcinoma

PubMed: MeSH publication types

  • Editorial
  • Comment

Cite this